Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasmin.

Source:http://linkedlifedata.com/resource/pubmed/id/1691750

Download in:

View as

General Info

PMID
1691750